Stock Earnings

Question 1

Quels sont les états financiers clés de Viridian Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Viridian Therapeutics Inc a un total d'actifs de $742, un bénéfice net loss de $-269

Question 2

Quels sont les ratios financiers clés pour VRDN ?

Accepted Answer

Le ratio de liquidité de Viridian Therapeutics Inc est 10.6, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de Viridian Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Viridian Therapeutics Inc largest revenue segment is Monoclonal Antibody, at a revenue of 302,000 in the most earnings release.For geography, United States is the primary market for Viridian Therapeutics Inc, at a revenue of 302,000.

Question 4

Viridian Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Viridian Therapeutics Inc a un bénéfice net loss de $-269

Question 5

Viridian Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Viridian Therapeutics Inc a un passif de 70

Question 6

Combien d'actions en circulation Viridian Therapeutics Inc a-t-elle ?

Accepted Answer

Viridian Therapeutics Inc a un total d'actions en circulation de 80.99

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	70	0	0	1	2	1
Revenue Growth (YoY)	--	--	-100%	-50%	100%	-75%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	77	61	94	35	25	13
Research & Development	321	237	159	100	56	27
Operating Expenses	398	299	254	136	82	41
Other Non Operating Income (Expenses)	0	--	--	--	--	--
Pretax Income	-301	-269	-237	-129	-79	-110
Income Tax Expense	--	--	--	--	--	--
Net Income	-301	-269	-237	-129	-79	-110
Net Income Growth	17%	14%	84%	63%	-28%	168%
Shares Outstanding (Diluted)	81.78	67.88	44.75	32.09	11.92	3.56
Shares Change (YoY)	23%	52%	39%	169%	235%	70%
EPS (Diluted)	-3.69	-3.97	-5.31	-4.05	-6.66	-31.1
EPS Growth	-5%	-25%	31%	-39%	-79%	55%
Free Cash Flow	-326	-232	-185	-94	-54	-29
Free Cash Flow Per Share	-3.98	-3.41	-4.13	-2.92	-4.53	-8.14
Gross Margin	--	--	--	--	--	--
Operating Margin	-468.57%	0%	0%	-13,400%	-3,950%	-4,000%
Profit Margin	-430%	0%	0%	-12,900%	-3,950%	-11,000%
Free Cash Flow Margin	-465.71%	0%	0%	-9,400%	-2,700%	-2,900%
EBITDA	-328	-299	-254	-134	-79	-40
EBITDA Margin	-468.57%	0%	0%	-13,400%	-3,950%	-4,000%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-328	-299	-254	-134	-79	-40
EBIT Margin	-468.57%	0%	0%	-13,400%	-3,950%	-4,000%
Effective Tax Rate	--	--	--	--	--	--

Viridian Therapeutics Inc (VRDN) Price

VRDN Stock Price Chart

VRDN Income

Follow-Up Questions